KFG Wealth Management LLC Has $529,000 Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

KFG Wealth Management LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,005 shares of the healthcare conglomerate’s stock after selling 36 shares during the period. KFG Wealth Management LLC’s holdings in UnitedHealth Group were worth $529,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of UNH. Ascension Capital Advisors Inc. bought a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $216,000. Bellecapital International Ltd. grew its stake in shares of UnitedHealth Group by 1.4% during the 4th quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock worth $7,277,000 after acquiring an additional 193 shares in the last quarter. Great Valley Advisor Group Inc. grew its stake in shares of UnitedHealth Group by 5.8% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock worth $17,292,000 after acquiring an additional 1,884 shares in the last quarter. Rise Advisors LLC grew its stake in shares of UnitedHealth Group by 326.0% during the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock worth $112,000 after acquiring an additional 163 shares in the last quarter. Finally, Gradient Investments LLC grew its stake in shares of UnitedHealth Group by 6.3% in the fourth quarter. Gradient Investments LLC now owns 84,278 shares of the healthcare conglomerate’s stock valued at $44,370,000 after buying an additional 5,023 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently weighed in on UNH. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Bank of America reissued a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Truist Financial reissued a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday. Stephens reaffirmed an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 8th. Finally, Barclays lifted their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research report on Wednesday. Four analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Price Performance

UNH stock traded up $8.11 during midday trading on Friday, reaching $501.29. The company had a trading volume of 6,616,632 shares, compared to its average volume of 4,553,088. The company has a market capitalization of $462.16 billion, a price-to-earnings ratio of 30.63, a price-to-earnings-growth ratio of 1.31 and a beta of 0.54. The stock has a 50 day moving average price of $488.97 and a 200-day moving average price of $515.22. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.26 earnings per share. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.74 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a yield of 1.50%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.